Creating Peace: Community-based Youth Violence Prevention to Address Racism and Discrimination
Launched by UNIVERSITY OF PITTSBURGH · Jul 13, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Creating Peace" clinical trial is looking at a new program designed to help young people, aged 14 to 19, deal with issues related to violence, racism, and discrimination. This program aims to teach important skills to prevent violence and promote understanding among peers. It focuses on creating a safe and supportive environment where young people can learn how to cope with their feelings and communicate better with each other.
To participate in this study, you must be between 14 and 19 years old and speak English. If you join, you will be part of a community effort to make positive changes, and you can expect to engage in discussions and activities that explore these important topics. This trial is currently recruiting participants, and your involvement could help shape future programs that support youth in dealing with violence and discrimination.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be ages 14-19 (inclusive)
- • Participants must speak English
- Exclusion Criteria:
- • Not ages 14-19 (inclusive)
- • Do not speak English
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Elizabeth Miller, MD, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials